Protein C Deficiency Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Protein C Deficiency
Protein C Deficiency is an inherited or, less commonly, acquired disorder that affects the body's ability to regulate blood clotting. Protein C is a natural anticoagulant, meaning it helps prevent excessive clotting. When there isn't enough functional Protein C, individuals are at a higher risk of developing blood clots, particularly deep vein thrombosis (DVT) in the legs or pulmonary embolism (PE) in the lungs. In severe cases, especially in newborns, it can lead to a life-threatening condition called purpura fulminans.
Diagnosis typically involves blood tests to measure protein C levels and activity. While some individuals may have a mild deficiency and never experience a clot, others face recurrent, serious clotting events that require careful management.
Common Treatments and Medications
Managing Protein C Deficiency primarily focuses on preventing blood clots. This often involves lifelong medication. The most common treatments include:
- Anticoagulants (Blood Thinners): Medications like warfarin (Coumadin®), rivaroxaban (Xarelto®), apixaban (Eliquis®), or dabigatran (Pradaxa®) are frequently prescribed. These drugs help prevent new clots from forming and stop existing clots from growing larger.
- Protein C Concentrate: In very severe cases, particularly in infants with purpura fulminans or during acute thrombotic events, Protein C concentrate (e.g., Ceprotin®) may be administered intravenously to temporarily replace the missing protein.
These medications are crucial for
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.